Mirioglu, S. Et Al. 2024. Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.. Clinical kidney journal , vol.17, no.7 .

Mirioglu, S., Hocaoglu, R. H., Velioglu, A., Ozluk, Y., Dirim, A. B., Oruc, A., ... Oto, Ö. A.(2024). Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.. Clinical kidney journal , vol.17, no.7.

Mirioglu, Safak Et Al. "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.," Clinical kidney journal , vol.17, no.7, 2024

Mirioglu, Safak Et Al. "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.." Clinical kidney journal , vol.17, no.7, 2024

Mirioglu, S. Et Al. (2024) . "Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.." Clinical kidney journal , vol.17, no.7.

@article{article, author={Safak Mirioglu Et Al. }, title={Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.}, journal={Clinical kidney journal}, year=2024}